Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating brain blood flow using contrast-enhanced ultrasound

Official title: Quantification of Cerebral Perfusion at the Patient's Bedside When Performing Contrast-enhanced Ultrasound in Neurointensive Care Patients

Run by Assistance Publique - Hôpitaux de Paris · NCT05893407 · Data updated 2026-11-12

This study is testing a new ultrasound method to see if it can help doctors check blood flow in the brains of patients with recent brain injuries.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedJuly 21, 2023
Main results expectedJuly 2025
Study endsJuly 2025
Registry record updatedJune 19, 2025
Trial IDNCT05893407 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who are admitted to the intensive care unit for acute brain injuries confirmed by CT or MRI.

Probably not a fit

Patients who are pregnant or have contraindications to the contrast agent used in the study will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess brain tissue perfusion in patients with acute brain injuries using contrast-enhanced ultrasound perfusion imaging (PerCEUS). It focuses on diagnosing brain tissue hypoperfusion by evaluating the heterogeneity of brain perfusion and correlating the results with standard multimodal monitoring techniques. The PerCEUS measurements will be performed at the bedside by a physician shortly after hospitalization, with data analyzed offline using specialized software. The study will involve selecting specific regions of interest in the brain to assess perfusion levels.

Why it matters

Potential benefit: If successful, this study could improve the diagnosis and management of acute brain injuries by providing real-time insights into brain perfusion.

How similar studies have gone: While the use of contrast-enhanced ultrasound for brain perfusion assessment is gaining interest, this specific approach is relatively novel and has not been extensively tested in similar studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18
* Intensive care unit admission for acute brain injury
* Proven acute brain injury by CT and/or MRI
* Requiring a contrast ultrasound imaging
* Informed consent of patient or relative

Exclusion Criteria:

* Pregnancy
* Not sufficient temporal window
* Contraindications to Sonovue ® : acute coronary syndromes, severe ischemic heart disease (requiring revascularization), pulmonary arterial hypertension \> 90 mmHg, right-left shunt, ARDS, dobutamine's use, known allergy or adverse reaction to Sonovue®
* Patient on State Medical Assistance

Where it's running

  • Lariboisière Hospital
    Paris, France
    Recruiting

Study contacts

  • Principal investigator: Romain BARTHELEMY, MD — AP-HP Lariboisière Hospital, Department of Anaesthesia and Intensive Care
  • Study coordinator: Romain BARTHELEMY, MD
  • Email: romain.barthelemy@aphp.fr
  • Phone: +33 (0)1 49 95 85 15

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.